Evaluation and Prediction of the Effect of EECP on HR-NICE Patients

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.

Also called NCT05718622

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05718622
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05718622. Randomized; triple masking; primary purpose treatment. Start 2022-11-10 (actual); primary completion 2026-11-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluation and Prediction of the Effect of EECP on HR-NICE Patients
Condition
Stroke, Ischemic
Intervention (Device)
real EECP
Intervention (Device)
sham EECP
Lead sponsor
First Affiliated Hospital Xi'an Jiaotong University (class: other)

Record details

Record id
cardio:ct-nct05718622
Content hash
4875889a2646fc51302434223f1a08bb1369a2c3c9dc43e49804dcd0f8378842